SEC Form 4 · accession 0001127602-16-061793
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Mahon
Officer — EVP & General Counsel
Period of report
Sep 1, 2016
Accepted (ET)
Sep 2, 2016 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 1, 2016 | M | 6,000 | $50.09 | A | 41,221 | D | |
| Common Stock | Sep 1, 2016 | D | 6,000 | $123.21 | D | 35,221 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking AwardF2 | $50.09 | Sep 1, 2016 | M | 6,000 | D | Sep 15, 2010 | Sep 15, 2019 | Common Stock | 6,000 | 50,000 | D |
Explanation of responses
- F1Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.